Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. more
Time Frame | OPTN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.34% | -2.82% | 0.15% |
1-Month Return | -18.62% | -4.22% | 1.78% |
3-Month Return | -47.78% | -9.52% | 8.7% |
6-Month Return | -60.62% | -3.45% | 12.24% |
1-Year Return | -58.26% | 5.62% | 30.9% |
3-Year Return | -69.48% | 3.8% | 30.19% |
5-Year Return | -94.83% | 39.68% | 91.72% |
10-Year Return | -97.43% | 105.02% | 203.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 34.63M | 49.12M | 74.65M | 76.28M | 70.99M | [{"date":"2019-12-31","value":45.4,"profit":true},{"date":"2020-12-31","value":64.39,"profit":true},{"date":"2021-12-31","value":97.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.07,"profit":true}] |
Cost of Revenue | 5.29M | 7.52M | 9.15M | 9.26M | 8.63M | [{"date":"2019-12-31","value":57.15,"profit":true},{"date":"2020-12-31","value":81.18,"profit":true},{"date":"2021-12-31","value":98.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.2,"profit":true}] |
Gross Profit | 29.34M | 41.60M | 65.50M | 67.01M | 62.35M | [{"date":"2019-12-31","value":43.78,"profit":true},{"date":"2020-12-31","value":62.07,"profit":true},{"date":"2021-12-31","value":97.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.05,"profit":true}] |
Gross Margin | 84.71% | 84.69% | 87.74% | 87.86% | 87.84% | [{"date":"2019-12-31","value":96.42,"profit":true},{"date":"2020-12-31","value":96.4,"profit":true},{"date":"2021-12-31","value":99.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.98,"profit":true}] |
Operating Expenses | 124.94M | 128.82M | 131.95M | 122.91M | 85.10M | [{"date":"2019-12-31","value":94.69,"profit":true},{"date":"2020-12-31","value":97.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.15,"profit":true},{"date":"2023-12-31","value":64.5,"profit":true}] |
Operating Income | (95.60M) | (87.22M) | (66.45M) | (55.90M) | (22.75M) | [{"date":"2019-12-31","value":-9560100000,"profit":false},{"date":"2020-12-31","value":-8721900000,"profit":false},{"date":"2021-12-31","value":-6645000000,"profit":false},{"date":"2022-12-31","value":-5589600000,"profit":false},{"date":"2023-12-31","value":-2274800000,"profit":false}] |
Total Non-Operating Income/Expense | (21.72M) | (25.15M) | (31.77M) | (35.27M) | (29.74M) | [{"date":"2019-12-31","value":-2171600000,"profit":false},{"date":"2020-12-31","value":-2514900000,"profit":false},{"date":"2021-12-31","value":-3176700000,"profit":false},{"date":"2022-12-31","value":-3526700000,"profit":false},{"date":"2023-12-31","value":-2973600000,"profit":false}] |
Pre-Tax Income | (110.05M) | (99.79M) | (82.30M) | (74.83M) | (35.48M) | [{"date":"2019-12-31","value":-11005300000,"profit":false},{"date":"2020-12-31","value":-9978600000,"profit":false},{"date":"2021-12-31","value":-8229600000,"profit":false},{"date":"2022-12-31","value":-7483300000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}] |
Income Taxes | (1.11M) | (1.46M) | (646.00K) | 1.56M | 234.10K | [{"date":"2019-12-31","value":-70.93,"profit":false},{"date":"2020-12-31","value":-93.21,"profit":false},{"date":"2021-12-31","value":-41.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.99,"profit":true}] |
Income After Taxes | (108.94M) | (98.33M) | (81.65M) | (76.39M) | (35.72M) | [{"date":"2019-12-31","value":-10894500000,"profit":false},{"date":"2020-12-31","value":-9833000000,"profit":false},{"date":"2021-12-31","value":-8165000000,"profit":false},{"date":"2022-12-31","value":-7639500000,"profit":false},{"date":"2023-12-31","value":-3571710500,"profit":false}] |
Income From Continuous Operations | (110.05M) | (99.78M) | (82.37M) | (72.23M) | (35.48M) | [{"date":"2019-12-31","value":-11005300000,"profit":false},{"date":"2020-12-31","value":-9978500000,"profit":false},{"date":"2021-12-31","value":-8237100000,"profit":false},{"date":"2022-12-31","value":-7222600000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (108.94M) | (98.33M) | (81.65M) | (76.39M) | (35.48M) | [{"date":"2019-12-31","value":-10894500000,"profit":false},{"date":"2020-12-31","value":-9833000000,"profit":false},{"date":"2021-12-31","value":-8165000000,"profit":false},{"date":"2022-12-31","value":-7639500000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}] |
EPS (Diluted) | (2.63) | (2.08) | (1.48) | (0.89) | (0.32) | [{"date":"2019-12-31","value":-263,"profit":false},{"date":"2020-12-31","value":-208,"profit":false},{"date":"2021-12-31","value":-148,"profit":false},{"date":"2022-12-31","value":-89,"profit":false},{"date":"2023-12-31","value":-32,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
OPTN | |
---|---|
Cash Ratio | 0.51 |
Current Ratio | 0.79 |
Quick Ratio | 0.72 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OPTN | |
---|---|
ROA (LTM) | -10.32% |
ROE (LTM) | -1050.50% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OPTN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.31 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.31 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OPTN | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.99 |
P/B | 24.26 |
Price/FCF | NM |
EV/R | 1.60 |
EV/Ebitda | NM |
OptiNose (OPTN) share price today is $0.486
Yes, Indians can buy shares of OptiNose (OPTN) on Vested. To buy OptiNose from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OPTN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of OptiNose (OPTN) via the Vested app. You can start investing in OptiNose (OPTN) with a minimum investment of $1.
You can invest in shares of OptiNose (OPTN) via Vested in three simple steps:
The 52-week high price of OptiNose (OPTN) is $2.1. The 52-week low price of OptiNose (OPTN) is $0.32.
The price-to-earnings (P/E) ratio of OptiNose (OPTN) is
The price-to-book (P/B) ratio of OptiNose (OPTN) is 24.26
The dividend yield of OptiNose (OPTN) is 0.00%
The market capitalization of OptiNose (OPTN) is $74.66M
The stock symbol (or ticker) of OptiNose is OPTN